磷石膏/聚氨基酸医用多孔复合材料的制备与表征

Preparation and properties of phosphogypsum/amino acid copolymer porous composite for medical application

  • 摘要: 用化学共沉淀法合成了钙磷原子比(Ca/P)为1.50和1.67的磷石膏(PG), 用熔融聚合法制备四元氨基酸共聚物(PAA4), 用挤出发泡法制备了两种磷石膏/四元氨基酸共聚物(PG/PAA4)多孔复合材料。通过TGA、SEM、XRD、IR、EDS等对两种复合材料的组成结构进行了表征, 并研究了复合材料在磷酸缓冲液(PBS)中的体外降解性能。结果表明: 无机组分PG在两种复合材料中分布均一, 质量分数均为60%左右; PG/PAA4复合材料的孔径为100~400 μm, 孔隙率在60%左右; 多孔复合材料的有机和无机相之间有化学作用。PG/PAA4复合材料具有良好的体外降解性能, 其失重率随PG钙磷比的增加而增加, 降解液的pH值维持在6.9~7.4之间。PG/PAA4复合材料降解后, 其表面沉积了片状钙磷化合物, 推测该复合材料可能具有生物活性。

     

    Abstract: Phosphogypsum (PG) materials with the ratio of calcium and phosphorus (Ca/P) of 1.50 and 1.67 were synthesized by the chemical coprecipitation, poly(lactide-amino acid) copolymer (PAA4) was synthesized through the melt polycondensation, and two kinds of PG/PAA4 porous composites for the medical application with Ca/P of 1.50 and 1.67 were prepared by the extrusion foaming method. The morphology, microstructure and composition of the composites were characterized by TGA、XRD、IR、SEM、EDS, and the in vitro degradability of the composites were investigated through phosphate buffer solution (PBS). The results show that the porous composites have good uniformity with the phosphogypsum of around 60% (mass fraction) dispersed in the PG/PAA4 composites. The porous composites have the pore size ranging from 100 to 400 μm with the porosity of 60%. Some chemical interactions occur between the inorganic (PG) and organic phases (PAA4) in the composites. The composites exhibit good degradability in PBS and their degradability is enhanced by the increase of the Ca/P of PG. No obvious change of pH value of the solution is found during the composites soaking into PBS, which ranges from 6.9 to 7.4. Presumably, the composites have bioactivity with the apatite deposited on their surfaces after soaking in PBS.

     

/

返回文章
返回